SUNLO
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

SUNLO Trademark

Serial Number: 87116827

SUNLO is a trademark filed by ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED on July 26, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (253 trademarks)

CLONSHAUGH BUSINESS & TECHNOLOGY PARK
COOLOCK, DUBLIN 17 , IE

Entity Type: 77

Trademark Details

Filing Date

July 26, 2016

Registration Date

Not Registered

Published for Opposition

November 1, 2016

Goods & Services

Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations; sterile ointments; ocular wetting solutions, artificial tears and formulations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 27, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 27, 2020 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 21, 2019 EXRA
SOU EXTENSION 5 GRANTED
Mar 20, 2019 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 20, 2019 AITU
SOU EXTENSION 5 FILED
Mar 15, 2019 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 15, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 6, 2018 EXRA
SOU EXTENSION 4 GRANTED
Nov 2, 2018 EX4G
SOU EXTENSION 4 FILED
Nov 2, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 2, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 16, 2018 EXRA
SOU EXTENSION 3 GRANTED
Jun 14, 2018 EX3G
SOU EXTENSION 3 FILED
Jun 14, 2018 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 14, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 17, 2017 EXRA
SOU EXTENSION 2 GRANTED
Nov 15, 2017 EX2G
SOU EXTENSION 2 FILED
Nov 15, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 15, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 9, 2017 EXRA
SOU EXTENSION 1 GRANTED
May 5, 2017 EX1G
SOU EXTENSION 1 FILED
May 5, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
May 5, 2017 EEXT
ASSIGNED TO EXAMINER
Jan 17, 2017 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 27, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 1, 2016 NPUB
PUBLISHED FOR OPPOSITION
Nov 1, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 12, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 27, 2016 PREV
ASSIGNED TO LIE
Sep 27, 2016 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 13, 2016 CNSA
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 2, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 2, 2016 GNSL
SUSPENSION LETTER WRITTEN
Sep 2, 2016 CNSL
ASSIGNED TO EXAMINER
Sep 1, 2016 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Jul 30, 2016 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2016 NWOS
NEW APPLICATION ENTERED
Jul 29, 2016 NWAP